Ooculex-pharmaceuticals

Oxular

Oxular develops drug delivery devices and sustained-release therapeutics for treating retinal diseases in patients with vision disorders.

Biophta

This company develops self-administered ocular inserts providing seven-day continuous drug release for patients with glaucoma and macular oedema.

EyeBio

This biotechnology company develops ocular therapies to treat retinal diseases such as diabetic macular edema and age-related macular degeneration for patients with vision loss.

Perfuse Therapeutics

The company develops sustained-release intravitreal therapies to treat ischemia-driven ocular diseases for patients with conditions like glaucoma and diabetic retinopathy.

Oculis

This biopharmaceutical company develops topical therapies and delivery systems to treat neuro-ophthalmic and ophthalmic diseases for patients with unmet medical needs.

Re-vana

The company develops biodegradable ocular implants and drug delivery systems to treat sight-threatening diseases for pharmaceutical partners and patients.

Iveric Bio

This biopharmaceutical company develops therapeutic treatments for retinal diseases and provides these medicines to patients with age-related macular degeneration and inherited conditions.

Eyebiotech Limited

This clinical-stage biotechnology company develops therapies for retinal diseases, such as diabetic macular edema and age-related macular degeneration, to protect and restore patient vision.